GlaxoSmithKline's total assets for Q3 2025 were £―, a decrease of ― from the previous quarter. GB:GSK total liabilities were £― for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.